Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimter PM 2mg/500mg/7.5mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Bluewaterresearch

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (7.5mg)

Overview Glimter PM 2mg/500mg/7.5mg Tablet SR

Glycemic Control Tablet SR (2mg/500mg/7.5mg) is a triple-combination medication managing blood glucose. This formulation, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It optimizes insulin utilization, thus reducing blood sugar. Adhere strictly to your physician's prescribed dosage and regimen for Glycemic Control Tablet SR. Ingestion with food minimizes gastrointestinal discomfort. Missed doses should be taken promptly, unless nearing the next scheduled dose; in this case, omit the missed dose and resume the usual schedule. Never double the dose. An overdose can result in hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol, or skipped meals increases the risk of hypoglycemia; consistent blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and upper respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Baseline kidney function tests are mandatory before initiating therapy. Limit alcohol consumption to reduce the potential for increased side effects.

Primary Ingredients of Glimter PM 2mg/500mg/7.5mg Tablet SR

There is no text provided to rephrase.

Uses of Glimter PM 2mg/500mg/7.5mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimter PM 2mg/500mg/7.5mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Glimter PM 2mg/500mg/7.5mg Extended-Release Tablets with food.

Common Side effects of Glimter PM 2mg/500mg/7.5mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Glimter PM 2mg/500mg/7.5mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; do not fragment, pulverize, or chew it. Consume Glimter PM 2mg/500mg/7.5mg Extended-Release tablets with food.

How Glimter PM 2mg/500mg/7.5mg Tablet SR works:

Glimter PM 2mg/500mg/7.5mg Extended-Release tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct modes of action to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Pioglitazone, a thiazolidinedione, further augments insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimter PM 2mg/500mg/7.5mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimter PM 2mg/500mg/7.5mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glimter PM tablets (2mg/500mg/7.5mg) are likely not safe for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimter PM 2mg/500mg/7.5mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. For individuals with severe kidney disease, Glimter PM 2mg/500mg/7.5mg SR tablets are contraindicated. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimter PM 2mg/500mg/7.5mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimter PM 2mg/500mg/7.5mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glimter PM 2mg/500mg/7.5mg Tablet SR :

Should you forget to take your Glimter PM 2mg/500mg/7.5mg SR Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimter PM 2mg/500mg/7.5mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimter PM 2mg/500mg/7.5mg Tablet SR

Consuming alcohol while taking Glimter PM 2mg/500mg/7.5mg SR tablets is unsafe. Alcohol consumption can lead to dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Consult your physician prior to using Glimter PM 2mg/500mg/7.5mg Extended-Release Tablets if you experience congestive heart failure, renal impairment, hepatic dysfunction, or papilledema. Disclose your pregnancy status, breastfeeding status, or premenopausal state to your doctor. Also, inform your doctor of all medications you are currently taking, including prescription and over-the-counter drugs, vitamins, and herbal remedies.
Glimter PM 2mg/500mg/7.5mg SR tablets may lead to vitamin B12 deficiency due to their metformin content. Prolonged use impairs the stomach's absorption of vitamin B12.
Indeed, taking Glimter PM 2mg/500mg/7.5mg Extended-Release Tablets may lead to hypoglycemia. Low blood sugar can manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, rapid pulse, and feelings of unease or tremors. This risk increases with skipped or late meals, alcohol consumption, excessive physical activity, or concomitant use of other diabetes medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as sweets or chocolate, is advisable.
Retain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and other individuals.
Glimter PM 2mg/500mg/7.5m...
62
MRP 75
17% off